Characterization of the Immune-Modulating Properties of Different β-Glucans on Myeloid Dendritic Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25189914 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hannah Rainer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Section Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany. Hauptthemen laut MEDLINE: Dendritic Cells, beta-Glucans, Lectins, C-Type, Cytokines. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation.
Abstract (Originalsprache)
In allergen-specific immunotherapy, adjuvants are explored for modulating allergen-specific Th2 immune responses to re-establish clinical tolerance. One promising class of adjuvants are β-glucans, which are naturally derived sugar structures and components of dietary fibers that activate C-type lectin (CLR)-, “Toll”-like receptors (TLRs), and complement receptors (CRs). We characterized the immune-modulating properties of six commercially available β-glucans, using immunological (receptor activation, cytokine secretion, and T cell modulating potential) as well as metabolic parameters (metabolic state) in mouse bone marrow-derived myeloid dendritic cells (mDCs). All tested β-glucans activated the CLR Dectin-1a, whereas TLR2 was predominantly activated by Zymosan. Further, the tested β-glucans differentially induced mDC-derived cytokine secretion and activation of mDC metabolism. Subsequent analyses focusing on Zymosan, Zymosan depleted, β-1,3 glucan, and β-1,3 1,6 glucan revealed robust mDC activation with the upregulation of the cluster of differentiation 40 (CD40), CD80, CD86, and MHCII to different extents. β-glucan-induced cytokine secretion was shown to be, in part, dependent on the activation of the intracellular Dectin-1 adapter molecule Syk. In co-cultures of mDCs with Th2-biased CD4+ T cells isolated from birch allergen Bet v 1 plus aluminum hydroxide (Alum)-sensitized mice, these four β-glucans suppressed allergen-induced IL-5 secretion, while only Zymosan and β-1,3 glucan significantly suppressed allergen-induced interferon gamma (IFNγ) secretion, suggesting the tested β-glucans to have distinct effects on mDC T cell priming capacity. Our experiments indicate that β-glucans have distinct immune-modulating properties, making them interesting adjuvants for future allergy treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section Molecular Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.
- Section Research Allergology, Division of Allergology, Paul-Ehrlich-Institut, 63225 Langen, Germany.
- Laboratory of Food and Biomolecular Science, Graduate School of Agricultural Science, Tohoku University, Sendai 980-8576, Japan.
ORCID-Profile: Yen-Ju Lin, Stephan Scheurer, Stefan Schülke
Förderung
- German Research Foundation
Zitieren
APA
Rainer, H., Goretzki, A., Lin, Y. J., Schiller, H. R., Krause, M., Döring, S., Strecker, D., Junker, A. C., Wolfheimer, S., Toda, M., Scheurer, S., & Schülke, S. (2024). Characterization of the Immune-Modulating Properties of Different β-Glucans on Myeloid Dendritic Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25189914
Vancouver
Rainer H, Goretzki A, Lin YJ, Schiller HR, Krause M, Döring S, et al. Characterization of the Immune-Modulating Properties of Different β-Glucans on Myeloid Dendritic Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25189914
BibTeX
@article{Rainer2024,
author = {Rainer, Hannah and Goretzki, Alexandra and Lin, Yen-Ju and Schiller, Hannah Ruth and Krause, Maren and Döring, Sascha and Strecker, Daniel and Junker, Ann-Christine and Wolfheimer, Sonja and Toda, Masako and Scheurer, Stephan and Schülke, Stefan},
title = {Characterization of the Immune-Modulating Properties of Different β-Glucans on Myeloid Dendritic Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25189914}
}
EUVIMED